Literature DB >> 6322120

Nucleotide sequences of the retroviral long terminal repeats and their adjacent regions.

H R Chen, W C Barker.   

Abstract

The nucleotide sequences of the LTRs and their adjacent regions from 19 type C and one type B retrovirus were compared. Salient features are: (a) The R regions in the genomes of most of the type C retroviruses begin with GC and end with CA. (b) The mammalian type C retroviruses have a polyadenylation signal "AATAAA" in the R region, and most have a "CAT" box and a "TATA" box in the U3 region. (c) The avian type C retroviruses have an AATAAA sequence, and some also have "CAT-like" and "TATA-like" boxes, in the U3 region. (d) As with many transposable elements, the IR regions of the proviruses begin with TG and end with CA, and the DR sequences in the host genomes flanking the proviruses are different from one another. Although SNV is an avian retrovirus, the nucleotide sequences in the R, U5, TBS, and PU region are more similar to the mammalian type C than to the avian type C retroviruses.

Entities:  

Mesh:

Year:  1984        PMID: 6322120      PMCID: PMC318619          DOI: 10.1093/nar/12.4.1767

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  5'-terminal nucleotide sequences of the Rauscher leukemia virus and gibbon ape leukemia virus genomes exhibit a high degree of correspondence.

Authors:  G G Lovinger; G Schochetman
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  tRNATrp as primer for RNA-directed DNA polymerase: structural determinants of function.

Authors:  B Cordell; R Swanstrom; H M Goodman; J M Bishop
Journal:  J Biol Chem       Date:  1979-03-25       Impact factor: 5.157

3.  Transposable elements.

Authors:  M P Calos; J H Miller
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

4.  Sequence of retrovirus provirus resembles that of bacterial transposable elements.

Authors:  K Shimotohno; S Mizutani; H M Temin
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

5.  Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.

Authors:  R Dhar; W L McClements; L W Enquist; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene.

Authors:  K H Klempnauer; T J Gonda; J M Bishop
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  A detailed model of reverse transcription and tests of crucial aspects.

Authors:  E Gilboa; S W Mitra; S Goff; D Baltimore
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

8.  Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.

Authors:  C Van Beveren; J G Goddard; A Berns; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Specific antigenic relationships between the RNA-dependent DNA polymerases of avian reticuloendotheliosis viruses and mammalian type C retroviruses.

Authors:  G Bauer; H M Temin
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

10.  tRNA's and priming of RNA-directed DNA synthesis in mouse mammary tumor virus.

Authors:  G Peters; C Glover
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

View more
  41 in total

1.  Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells.

Authors:  G La Mantia; D Maglione; G Pengue; A Di Cristofano; A Simeone; L Lanfrancone; L Lania
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

2.  Functional heterogeneity of a large family of human LTR-like promoters and enhancers.

Authors:  A Feuchter; D Mager
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

3.  The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells.

Authors:  G Scheef; N Fischer; U Krach; R R Tönjes
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Identification of a full-length cDNA for an endogenous retrovirus of miniature swine.

Authors:  D E Akiyoshi; M Denaro; H Zhu; J L Greenstein; P Banerjee; J A Fishman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Identification of a second retrotransposon-related element in the genome of Physarum polycephalum.

Authors:  K J McCurrach; H M Rothnie; N Hardman; L A Glover
Journal:  Curr Genet       Date:  1990-05       Impact factor: 3.886

7.  Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences.

Authors:  S Lovmand; N O Kjeldgaard; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes.

Authors:  M Ono
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Evolutionary conservation of orthoretroviral long terminal repeats (LTRs) and ab initio detection of single LTRs in genomic data.

Authors:  Farid Benachenhou; Patric Jern; Merja Oja; Göran Sperber; Vidar Blikstad; Panu Somervuo; Samuel Kaski; Jonas Blomberg
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.